Georgeanna Klingensmith MD

Pediatric Endocrinology•Aurora, CO

Barbara Davis Center, University of Colorado

Join to View Full Profile

1775 Aurora CtAurora, CO 80045
Phone+1 303-724-2323
Fax+1 303-724-6779

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1974 - 1976
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1972 - 1974
University of Colorado School of MedicineInternship, Transitional Year, 1971 - 1972
Duke University School of MedicineClass of 1971

Certifications & Licensure

CO State Medical License Active through 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Clinical Trials

In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System Start of enrollment: 2008 Dec 01
Completed
Not Applicable
Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults Start of enrollment: 2013 Nov 01
Completed
Phase 3
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes Start of enrollment: 2013 Nov 01
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

A Randomized Phase 3 Study Evaluating the Efficacy and Safety of Alogliptin in Pediatric Participants with Type 2 Diabetes Mellitus.
Xuejun Victor Peng, Georgeanna Klingensmith, Daniel S Hsia, Yunlong Xie, Richard Czerniak
Diabetes Therapy. 2025-03-04
26 citations
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO...
Lori M Laffel, Thomas Danne, Georgeanna J Klingensmith, William V Tamborlane, Steven Willi
The Lancet. Diabetes & Endocrinology. 2023-03-01
1 citations
ZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition index.
Janine Higgins, Philip Zeitler, Kimberly L Drews, Silva Arslanian, Kenneth Copeland
Journal of Clinical & Translational Endocrinology. 2022-09-01

Lectures

Visit Frequency Influences HbA1c at 12 Months in Children with Type 1 Diabetes (T1D)
Aurora, CO - 6/14/2014
Feasibility and Acceptability of Shared Medical Appointments in Middle School Populations with Type 1 Diabetes
Aurora, CO - 6/15/2014

Press Mentions

Youth with Type 1 Diabetes May Suffer Health Risks When Transitioning from Pediatric to Adult CareFebruary 10th, 2016

Grant Support

Gonadotrophin Releasing Hormone Antagonist/Treatment Isosexual PrecocityNational Center For Research Resources1987–1988